| Period Ending | 31-Dec-2011 | 30-Sep-2011 | 30-Jun-2011 | 31-Mar-2011 |
|---|
|
Total Revenue
|
54,566,000
|
52,939,000
|
53,303,000
|
47,389,000
| | Cost of Revenue | 19,556,000 | 40,655,000 | 24,150,000 | 27,145,000 | | |
Gross Profit
|
35,010,000
|
12,284,000
|
29,153,000
|
20,244,000
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative |
-
|
-
|
-
|
-
|
|
Non Recurring |
-
|
-
|
-
|
-
|
|
Others |
-
|
-
|
-
|
-
|
|
|
|
Total Operating Expenses | 39,661,000 | 35,711,000 | 33,463,000 | 31,057,000 | | | |
Operating Income or Loss
|
14,905,000
|
17,228,000
|
19,840,000
|
16,332,000
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net |
-
|
-
|
-
|
-
|
|
Earnings Before Interest And Taxes | 14,905,000 | 17,228,000 | 19,840,000 | 16,332,000 |
|
Interest Expense | (778,000) | (840,000) | (1,060,000) | (453,000) |
|
Income Before Tax |
-
|
-
|
-
|
-
|
|
Income Tax Expense | 2,895,000 | 2,066,000 | 5,273,000 | 3,717,000 |
|
Minority Interest | (1,460,000) | (1,678,000) | (1,986,000) | (1,708,000) |
|
|
|
Net Income From Continuing Ops | 11,576,000 | 14,513,000 | 14,245,000 | 12,175,000 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
|
-
|
-
|
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | | |
Net Income
|
10,116,000
|
12,835,000
|
12,259,000
|
10,467,000
| | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | |
Net Income Applicable To Common Shares
|
-
|
-
|
-
|
-
|
|